V

VKTX

Viking Therapeutics Inc

31.87

-0.53-1.62%
Opening11:43 04/29 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Total Assets

715.73M

908.32M

368.49M

168.53M

210.66M

Total Current Assets

715.60M

907.22M

367.23M

167.04M

210.53M

Total Non Current Assets

131.00K

1.10M

1.26M

1.49M

134.00K

Total Liabilities

76.67M

28.04M

20.07M

23.21M

8.78M

Total Current Liabilities

76.67M

27.41M

19.14M

21.95M

8.78M

Total Non Current Liabilities

0

630.00K

936.00K

1.26M

0

Total Equity

639.06M

880.28M

348.42M

145.32M

201.88M

Total Stockholders Equity

639.06M

880.28M

348.42M

145.32M

201.88M

Minority Interest

--

--

--

--

--

Total Liabilities & Shareholders Equity

715.73M

908.32M

368.49M

168.53M

210.66M

Total Common Shares Outstanding

114.79M

111.57M

100.11M

78.26M

78.25M

Total Preferred Shares Outstanding

--

--

--

--

--